eClinical Solutions Market size is expected to reach USD 21.8 billion by 2030
eClinical Solutions Industry Overview
The global eClinical solutions market size was estimated at USD 7.89 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.9% from 2023 to 2030. Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, the growing incorporation of software solutions in clinical trials is also projected to provide a fillip to the market. The COVID-19 pandemic boosts the adoption of the market, as companies in the market were investing in better healthcare IT solutions to help in tackling the pandemic.
For instance, in April 2020, eClinical Solutions LLC, developed the elluminate COVID-19 analytics, which was based on feedback from the industry and its clients for helping the sponsors manage the impact of COVID-19 on their ongoing clinical trials. The burgeoning trend of outsourcing clinical trials to contract research organizations (CROs) along with a rising number of CROs and life sciences organizations is poised to help the market gain tremendous traction in the coming years. In addition, growing research programs in Asian countries and the development of cost-effective modules are anticipated to stir up the demand for eClinical solutions.
Gather more insights about the market drivers, restrains and growth of the Global eClinical Solutions Market
Moreover, the presence of a stringent regulatory structure for clinical trials and a heightened need for safety monitoring is playing a vital role in the growth of the market for eClinical solutions in developed economies such as the U.S.For instance, the U.S. Department of Health and Human Services and the National Institutes of Health are tightening clinical trial registration requirements and promoting clinical data sharing. Surging demand for software solutions for clinical trials by pharma and biopharma companies is one of the primary growth stimulants of the market for eClinical solutions. Apart from this, increasing government grants to substantiate trials and widening the end-user base for eClinical solutions are likely to boost the market for eClinical solutions during the review period.
Browse through Grand View Research's Healthcare IT Industry Research Reports.
- Cognitive Assessment And Training In Healthcare Market: The global cognitive assessment and training in healthcare market size was valued at USD 3.42 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 25.5% from 2022 to 2030.
- Tele-Epilepsy Market: The global tele-epilepsy market size was valued at USD 0.32 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 15.7% from 2022 to 2030.
Market Share Insights
- October 2020: Oracle entered into collaboration with FHI Clinical Inc. for improving clinical trial efficiency and to get therapies to market faster.
- April 2020: eClinical Solutions LLC, developed the elluminate COVID-19 analytics, which was based on feedback from the industry and its clients for helping the sponsors manage the impact of COVID-19 on their ongoing clinical trials.
Key Companies Profile
Some of the prominent players in the eClinical solutions market include:
- Datatrak International, Inc.
- Oracle
- Parexel International Corporation
- Dassault Systemes
- Bioclinica
- CRF Health
- ERT Clinical
- eClinicalWorks
- IBM Watson Health
- Anju Life Sciences Software
- eClinical Solutions
Order a free sample PDF of eClinical Solutions Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment